AFT Pharmaceutical's multi-billion R&D opportunity
Welcome to HotCopper’s latest Watchlist, where we’ve been joined by AFT Pharmaceuticals (ASX:AFP) founder and chief executive Hartley Atkinson to discuss its expanding global reach and the @tentative” FDA approval the company has just hauled i...
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
| Tag | Subject | ||||||
|---|---|---|---|---|---|---|---|
| CSH | Ann:Change of Director's Interest - Dick Menting | 29/03/18 | 0 | 100 | |||
|
|||||||
| CSH | Ann:Section 2A - 31 December 2017 (Price Sensitive) | 06/03/18 | 0 | 68 | |||
|
|||||||
| CSH | Ann:Half Yearly Statements - 31 December 2017 (Price Sensitive) | 06/03/18 | 0 | 69 | |||
|
|||||||
| CSH | Ann:Change of Director's Interest - Dick Menting | 08:10 | 0 | 66 | |||
|
|||||||
| CSH | Ann:Renewal of Balwyn & Surrey Hills Franchise Agreements | 08:10 | 0 | 76 | |||
|
|||||||
See All Discussions
NSX News